Diseases, Conditions, Syndromes

Antibody neutralizes SARS and COVID-19 coronaviruses

An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19.

Oncology & Cancer

Turning on the 'off switch' in cancer cells

A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway ...

Neuroscience

New method to dampen nerve signals

Researchers at Linköping University in Sweden have discovered a previously unknown molecular binding site that can influence electrical impulses in nerves. The results are presented in the journal Science Advances. The discovery ...

Diseases, Conditions, Syndromes

Hepatitis C mutations 'outrun' immune systems, lab study shows

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide. Now, researchers at Johns Hopkins Medicine report that a novel ...

Medical research

Human antibodies block norovirus' point of entrance into cells

A team of scientists from Baylor College of Medicine and Vanderbilt University Medical Center have determined a mechanism by which human antibodies target and block noroviruses. Their study, which appears in the Proceedings ...

Oncology & Cancer

Stop the growth: Researchers take aim at cancer metastasis

Most cancer drugs today work by attacking tumor growth. Researchers at the University of Michigan Life Sciences Institute, however, are taking aim at a different piece of the cancer puzzle—preventing its ability to spread ...

page 1 from 3